Patents by Inventor Nathalie Taccoen

Nathalie Taccoen has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Pharmaceutical Composition Combining Tenatoprazole and an Anti-Inflammatory Agent
    Publication number: 20130217723
    Abstract: The invention relates to a novel pharmaceutical combination. The inventive pharmaceutical composition comprises a combination of tenatoprazole and one or more anti-inflammatory agents selected from non-steroid anti-inflammatory agents and cyclooxygenase-2 inhibitors. The invention is suitable for the treatment of painful and inflammatory manifestations.
    Type: Application
    Filed: March 25, 2013
    Publication date: August 22, 2013
    Applicants: MITSUBISHI PHARMA CORPORATION, SIDEM PHARMA
    Inventor: Nathalie TACCOEN
  • PHARMACEUTICAL COMPOSITION COMBINING TENATOPRAZOLE AND A HISTAMINE H2-RECEPTOR ANTAGONIST
    Publication number: 20120122919
    Abstract: The invention relates to a novel pharmaceutical combination. The inventive pharmaceutical composition, which is intended for the treatment of pathologies linked to gastric hyperacidity, comprises a combination of tenatoprazole and one or more histamine H2-receptor antagonists preferably selected from cimetidine, ranitidine, famotidine and nizatidine. The invention is particularly suitable for the treatment of duodenal and gastric ulcers and the symptoms of, and lesions caused by, gastroesophageal reflux.
    Type: Application
    Filed: November 15, 2011
    Publication date: May 17, 2012
    Applicants: MITSUBISHI PHARMA CORPORATION, SIDEM PHARMA
    Inventors: François Schutze, Suzy Charbit, Hervé Ficheux, Michel Homerin, Alain Taccoen, Nathalie Taccoen, Yoshio Inaba
  • USE OF TENATOPRAZOLE FOR THE TREATMENT OF GASTROESOPHAGEAL REFLUX DISEASE
    Publication number: 20110152314
    Abstract: The invention relates to a novel therapeutic application of tenatoprazole. Tenatoprazole and the salts thereof can be used in the production of a medicament for the treatment of atypical and esophageal symptoms of gastroesophageal reflux, gastrorrhagia and dyspepsia.
    Type: Application
    Filed: February 25, 2011
    Publication date: June 23, 2011
    Applicants: SIDEM PHARMA, MITSUBISHI PHARMA CORPORATION
    Inventors: Francois SCHUTZE, Suzy CHARBIT, Herve FICHEUX, Michel HOMERIN, Alain TACCOEN, Nathalie TACCOEN, Yoshio INABA
  • Pharmaceutical composition combining tenatoprazole and an anti-inflammatory agent
    Publication number: 20100048518
    Abstract: The invention relates to a novel pharmaceutical combination. The inventive pharmaceutical composition comprises a combination of tenatoprazole and one or more anti-inflammatory agents selected from non-steroid anti-inflammatory agents and cyclooxygenase-2 inhibitors. The invention is suitable for the treatment of painful and inflammatory manifestations.
    Type: Application
    Filed: October 27, 2009
    Publication date: February 25, 2010
    Applicants: Sidem Pharma, Mitsubishi Pharma Corporation
    Inventors: Francois Schutze, Suzy Charbit, Hervé Ficheux, Michel Homerin, Alain Taccoen, Nathalie Taccoen, Yoshio Inaba
  • Pharmaceutical composition combining tenatoprazole and an anti-inflamatory agent
    Publication number: 20060287284
    Abstract: The invention relates to a novel pharmaceutical combination. The inventive pharmaceutical composition comprises a combination of tenatoprazole and one or more anti-inflammatory agents preferably selected from non-steroid anti-inflammatory agents and cyclooxygenase-2 inhibitors. The invention is suitable for the treatment of painful and inflammatory manifestations.
    Type: Application
    Filed: October 21, 2003
    Publication date: December 21, 2006
    Applicants: Negma Gild, Mitsubishi Pharma Corporation
    Inventors: Francois Schutze, Suzy Charbit, Hervé Ficheux, Michel Homerin, Alain Taccoen, Nathalie Taccoen, Yoshio Inaba
  • Pharmaceutical composition combining tenatoprazole and a histamine h2-receptor antagonist
    Publication number: 20060241136
    Abstract: The invention relates to a novel pharmaceutical combination. The inventive pharmaceutical composition, which is intended for the treatment of pathologies linked to gastric hyperacidity, comprises a combination of tenatoprazole and one or more histamine H2-receptor antagonists preferably selected from cimetidine, ranitidine, famotidine and nizatidine. The invention is particularly suitable for the treatment of duodenal and gastric ulcers and the symptoms of, and lesions caused by, gastroesophageal reflux.
    Type: Application
    Filed: October 21, 2003
    Publication date: October 26, 2006
    Inventors: Francois Schutze, Suzy Charbit, Hervé Ficheux, Michel Homerin, Alain Taccoen, Nathalie Taccoen, Yoshio Inaba